Proteomics of toxoplasma gondii

Toxoplasma Gondii

Volumn , Issue , 2007, Pages 541-565

  Wastling, J M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882815760     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369542-0/50022-2     Document Type: Chapter

References (73)

1. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
2. Alexander D.L., Mital J., Ward G.E., Bradley P., Boothroyd J.C. Identification of the moving junction complex of Toxoplasma gondii: a collabora-tion between distinct secretory organelles. PLoS Pathog. 2005, 1:e17.
3. Beckers C.J., Dubremetz J.F., Mercereau-Puijalon O., Joiner K.A. The Toxoplasma gondii rhop-try protein ROP2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed host cell cytoplasm. J. Cell Biol. 1994, 127:947-961.
4. Beckers C.J., Wakefield T., Joiner K.A. The expression of Toxoplasma proteins in Neospora caninum and the identification of a gene encoding a novel rhoptry protein. Mol. Biochem. Parasitol. 1997, 89:209-223.
5. Bhatti M.M., Livingston M., Mullapudi N., Sullivan W.J. Pair of unusual GCN5 histone acetyl-transferases and ADA2 homologues in the protozoan parasite Toxoplasma gondii. Eukaryot. Cell 2006, 5:62-76.
6. Blader I.J., Manger I.D., Boothroyd J.C. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J. Biol. Chem. 2001, 276:24 223-24 231.
7. Bradley P.J., Boothroyd J.C. Identification of the pro-mature processing site of Toxoplasma ROP1 by mass spectrometry. Mol. Biochem. Parasitol. 1999, 100:103-109.
8. Bradley P.J., Ward C., Cheng S.J, et al. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J. Biol. Chem. 2005, 280:34 245-34 258.
9. Bradshaw R.A., Burlingame A.L. From proteins to proteomics. IUBMB Life 2005, 57:267-272.
10. Buxton D., Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology 1995, 110:S11-S16. (Suppl.).
11. Carey K.L., Westwood N.J., Mitchison T.J., Ward G.E. A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii. Proc. Natl Acad. Sci. USA 2004, 101:7433-7438.
12. Cleary M.D., Singh U., Blader I.J., Brewer J.L., Boothroyd J.C. Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expres-sion. Eukaryot. Cell 2002, 1:329-340.
13. Cleary M.D., Meiering C.D., Jan E., Guymon R., Boothroyd J.C. Biosynthetic labeling of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of mRNA synthesis and decay. Nature Biotechnol. 2005, 23:232-237.
14. Cohen A.M. Investigation of the anti-Toxoplasma activity of arprinocid and the application of proteomics to the analysis of drug-resistance. PhD Thesis 2002, University of Glasgow, UK.
15. Cohen A.M., Rumpel K., Coombs G.H., Wastling J.M. Characterisation of global protein expression by two-dimensional electrophoresis and mass spectrometry: proteomics of Toxoplasma gondii. Intl J. Parasitol. 2002, 32:39-51.
16. Cravatt B.F., Sorensen E.J. Chemical strate-gies for the global analysis of protein function. Curr. Opin. Chem. Biol. 2000, 4:663-668.
17. Delorme V., Cayla X., Faure G., Garcia A., Tardieux I. Actin dynamics is controlled by a casein kinase II and phosphatase 2C interplay on Toxoplasma gondii Toxofilin. Mol. Biol. Cell 2003, 14:1900-1912.
18. Dhingra V., Gupta M., Andacht T., Fu Z.F. New frontiers in proteomics research: a perspective. IntlJ. Pharmacol. 2005, 299:1-18.
19. Dlugonska H., Dytnerska K., Reichmann G., Stachelhaus S., Fischer H.G. Towards the Toxoplasma gondii proteome: position of 13 parasite excretory antigens on a standardized map of two-dimensionally separated tachyzoite protein. Parasitol. Res. 2001, 87:634-637.
20. Fischer H.G., Nitzgen B., Reichmann G., Gross U., Hadding U. Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol. Res. 1997, 83:637-641.
21. Florens L., Washburn M.P., Raine J.D., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
22. Gastens M.H., Fischer H.G. Toxoplasma gondii eukaryotic translation initiation factor 4A asso-ciated with tachyzoite virulence is down-regulated in the bradyzoite stage. Intl J. Parasitol. 2002, 32:1225-1234.
23. Geissler S., Sokolowska-Kohler W., Bollmann R., Jungblut P.R., Presber W. Toxoplasma gondii infection: analysis of serological response by 2-DE immunoblotting. FEMS Immunol. Med. Microbiol. 1999, 25:299-311.
24. Godovac-Zimmermann J., Kleiner O., Brown L.R., Drukier A.K. Perspectives in spicing up proteomics with splicing. Proteomics 2005, 5:699-709.
25. Gorg A., Weiss W., Dunn M.J. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4:3665-3685.
26. Greenbaum D., Medzihradszky K.F., Burlingame A., Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 2000, 7:569-581.
27. Greenbaum D., Baruch A., Hayrapetian L., et al. Chemical approaches for functionally probing the proteome. Mol. Cell Proteomics 2002, 1:60-68.
28. Greenbaum D.C., Baruch A., Grainger M., et al. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 2002, 298:2002-2006.
29. Gulle H., Schoel B., Kaufmann S.H. Direct blotting with viable cells of protein mixtures separated by two-dimensional gel electrophoresis. J. Immunol. Methods 1990, 133:253-261.
30. Haley-Vicente D., Edwards D.J. Proteomic informatics: in silico methods lead to data manage-ment challenges. Curr. Opin. Drug Discov. Devel. 2003, 6:322-332.
31. Hamady M., Cheung T.H., Resing K., Cios K.J., Knight R. Key challenges in proteomics and proteoinformatics. Progress in proteins. IEEE Eng. Med. Biol. Mag. 2005, 24:34-40.
32. Hancock W.S., Wu S.L., Stanley R.R., Gombocz E.A., et al. Publishing large proteome datasets: scientific policy meets emerging technologies. Trends Biotechnol. 2002, 20:S39-S44.
33. Ishihama Y., Oda Y., Tabata T., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell Proteomics 2005, 4:1265-1272.
34. Johnson J.R., Florens L., Carucci D.J., Yates J.R. Proteomics in malaria. J. Proteome Res. 2004, 3:296-306.
35. Jones A., Hunt E., Wastling J.M., Pizarro A., Stoeckert C.J. An object model and database for functional genomics. Bioinformatics 2004, 20:1583-1590.
36. Jones A., Faldas A., Foucher A., et al. Visualisation and analysis of proteomic data from the procyclic form of Trypanosoma brucei. Proteomics 2006, 6:259-267.
37. Karasov A.O., Boothroyd J.C., Arrizabalaga G. Identification and disruption of a rhoptry-localized homologue of sodium hydrogen exchangers in Toxoplasma gondii. Intl J. Parasitol. 2005, 35:285-291.
38. Kremer A., Schneider R., Terstappen G.C. A bioinformatics perspective on proteomics: data storage, analysis, and integration. Biosci. Rep. 2005, 25:95-106.
39. Lane C.S. Mass spectrometry-based proteomics in the life sciences. Cell Mol. Life Sci. 2005, 62:848-869.
40. Lasonder E., Ishihama Y., Andersen J.S., et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 2002, 419:537-542.
41. Lebrun M., Michelin A., El H.H., et al. The rhop-try neck protein RON4 re-localizes at the moving junction during Toxoplasma gondii invasion. Cell Microbiol. 2005, 7:1823-1833.
42. Leriche M.A., Dubremetz J.F. Characterization of the protein contents of rhoptries and dense granules of Toxoplasma gondii tachyzoites by subcel-lular fractionation and monoclonal ant. Mol. Biochem. Parasitol. 1991, 45:249-259.
43. Matrajt M., Donald R.G., Singh U., Roos D.S. Identification and characterization of differ-entiation mutants in the protozoan parasite Toxoplasma gondii. Mol. Microbiol. 2002, 44:735-747.
44. Miller S.A., Thathy V., Ajioka J.W., Blackman M.J., Kim K. TgSUB2 is a Toxoplasma gondii rhoptry organelle processing proteinase. Mol. Microbiol. 2003, 49:883-894.
45. Morrison R.S., Kinoshita Y., Johnson M.D., Conrads T.P. Proteomics in the postgenomic age. Adv. Protein Chem. 2003, 65:1-23.
46. Neudeck A., Stachelhaus S., Nischik N., Striepen B., Reichmann G., Fischer H.G. Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. Microbes Infect. 2002, 4:581-590.
47. Nirmalan N., Sims P.F., Hyde J.E. Quantitative proteomics of the human malaria para-site Plasmodium falciparum and its application to studies of development and inhibition. Mol. Microbiol. 2004, 52:1187-1199.
48. Nischik N., Schade B., Dytnerska K., Dlugonska H., Reichmann G., Fischer H.G. Attenuation of mouse-virulent Toxoplasma gondii parasites is associated with a decrease in interleukin-12-induc-ing tachyzoite activity and reduced expres actin, catalase and excretory proteins. Microbes Infect. 2001, 3:689-699.
49. Ossorio P.N., Schwartzman J.D., Boothroyd J.C. A Toxoplasma gondii rhoptry protein associated with host cell penetration has unusual charge asymmetry. Mol. Biochem. Parasitol. 1992, 50:1-15.
50. Paba J., Ricart C.A., Fontes W., et al. Proteomic analysis of Trypanosoma cruzi developmental stages using isotope-coded affinity tag reagents. J. Proteome Res. 2004, 3:517-524.
51. Phillips C.I., Bogyo M. Proteomics meets microbiology: technical advances in the global mapping of protein expression and function. Cell Microbiol. 2005, 7:1061-1076.
52. Poupel O., Boleti H., Axisa S., Couture-Tosi E., Tardieux I. Toxofilin, a novel actin-binding protein from Toxoplasma gondii, sequesters actin monomers and caps actin filaments. Mol. Biol. Cell 2000, 11:355-368.
53. Que X., Ngo H., Lawton J., et al. The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for para-site invasion and rhoptry protein processing. J. Biol. Chem. 2002, 277:25 791-25 797.
54. Reichmann G., Dlugonska H., Fischer H.G. Murine Th1 clone defines a 60 kD tachyzoite antigen of. Toxoplasma gondii. Parasite Immunol. 1997, 19:229-234.
55. Reichmann G., Dlugonska H., Hiszczynska-Sawicka E., Fischer H. Tachyzoite-specific isoform of Toxoplasma gondii lactate dehydrogenase is the target antigen of a murine CD4 (+) T-cell clone. Microbes Infect. 2001, 3:779-787.
56. Reichmann G., Dlugonska H., Fischer H.G. Characterization of TgROP9 (p36) , a novel rhoptry protein of Toxoplasma gondii tachyzoites identified by T cell clone. Mol. Biochem. Parasitol. 2002, 119:43-54.
57. Sadak A., Taghy Z., Fortier B., Dubremetz J.F. Characterization of a family of rhoptry proteins of. Toxoplasma gondii. Mol. Biochem. Parasitol. 1988, 29:203-211.
58. Sam-Yellowe T.Y., Florens L., Wang T., et al. Proteome analysis of rhoptry-enriched fractions isolated from Plasmodium merozoites. J. Proteome Res. 2004, 3:995-1001.
59. Schmidt F., Donahoe S., Hagens K., et al. Complementary analysis of the Mycobacterium tuber-culosis proteome by two-dimensional electrophoresis and isotope-coded affinity tag technology. Mol. Cell Proteomics 2004, 3:24-42.
60. Sibley L.D., Mordue D.G., Su C., Robben P.M., Howe D.K. Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. Philos. Trans. R. Soc. Lond B Biol. Sci. 2002, 357:81-88.
61. Singh U., Brewer J.L., Boothroyd J.C. Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction. Mol. Microbiol. 2002, 44:721-733.
62. Smolka M.B., Zhou H., Purkayastha S., Aebersold R. Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis. Anal. Biochem. 2001, 297:25-31.
63. Souchelnytskyi S. Bridging proteomics and systems biology: what are the roads to be traveled?. Proteomics 2005, 5:4123-4137.
64. Spellman P.T., Miller M., Stewart J., et al. Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol. 2002, 3. research 0046.1-0046.9.
65. Steinberg T.H., Jones L.J., Haugland R.P., Singer V.L. SYPRO orange and SYPRO red protein gel stains: one-step fluorescent staining of denaturing gels for detection of nanogram levels of protein. Anal. Biochem. 1996, 239:223-237.
66. Stenzel W., Soltek S., Schluter D., Deckert M. The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephal. J. Neuropathol. Exp. Neurol. 2004, 63:631-640.
67. Taylor C.F., Paton N.W., Garwood K.L., et al. A systematic approach to modeling, capturing, and disseminating proteomics experimental data. Nature Biotechnol. 2003, 21:247-254.
68. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multi-dimensional protein identification technology. Nature Biotechnol. 2001, 19:242-247.
69. Wastling J.M., Bradley P.J. Proteomic analysis of the rhoptry organelles of Toxoplasma gondii. The Biology of Toxoplasma gondii 2007, Horizon Press, Norwich. D. Soldati, J. Ajioka (Eds.).
70. Yates J.R. Mass spectral analysis in proteomics. Annu. Rev. Biophys. Biomol. Struct. 2004, 33:297-316.
71. Yates J.R., Gilchrist A., Howell K.E., Bergeron J.J. Related articles, links, abstract. Proteomics of organelles and large cellular structures. Nature Rev. Mol. Cell Biol. 2005, 6:702-714.
72. Zhou X.W., Blackman M.J., Howell S.A., Carruthers V.B. Proteomic analysis of cleavage events reveals a dynamic two-step mechanism for proteolysis of a key parasite adhesive complex. Mol. Cell Proteomics 2004, 3:565-576.
73. Zhou X.W., Kafsack B.F., Cole R.N., Beckett P., Shen R.F., Carruthers V.B. The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins. J. Biol. Chem. 2005, 280:34 233-34 244.